We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

243 hedge funds and large institutions have $559M invested in First Trust NYSE Arca Biotechnology Index Fund in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 97 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 257243 (-14)

12.66% less ownership

Funds ownership: 60.21%47.55% (-13%)

25% less capital invested

Capital invested by funds: $746M → $559M (-$187M)

36% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 28

38% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 97

Holders
243
Holders Change
-14
Holders Change %
-5.45%
% of All Funds
3.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
18
Increased
60
Reduced
97
Closed
28
Calls
$2.31M
Puts
Net Calls
+$2.31M
Net Calls Change
+$1.36M
Name Holding Trade Value Shares
Change
Change in
Stake
UAG
126
United Advisor Group
Ohio
$363K +$360K +2,359 New
GWSG
127
GPS Wealth Strategies Group
Colorado
$340K +$27.3K +179 +9%
NS
128
NBC Securities
Alabama
$339K -$15.7K -103 -4%
AFA
129
American Financial Advisors
Georgia
$335K -$25.6K -168 -7%
CAM
130
Cozad Asset Management
Illinois
$332K
TA
131
TFG Advisers
Michigan
$329K -$12.2K -80 -4%
SP
132
Stablepoint Partners
Massachusetts
$328K +$89.7K +588 +38%
Jones Financial Companies
133
Jones Financial Companies
Missouri
$326K +$129K +846 +66%
MGIA
134
Moneta Group Investment Advisors
Missouri
$324K
SWP
135
Stratos Wealth Partners
Ohio
$308K -$525K -3,443 -63%
DWP
136
Destiny Wealth Partners
Florida
$298K
VCM
137
Virtue Capital Management
Tennessee
$286K
WIP
138
WealthCare Investment Partners
Rhode Island
$283K +$4.58K +30 +2%
IFG
139
Independent Financial Group
California
$278K +$5.18K +34 +2%
PWP
140
Pursue Wealth Partners
California
$277K
BTWM
141
Brass Tax Wealth Management
Ohio
$271K +$269K +1,765 New
TSS
142
Two Sigma Securities
New York
$269K -$202K -1,328 -43%
SB
143
Strategic Blueprint
Georgia
$266K -$2.59K -17 -1%
GCP
144
GSA Capital Partners
United Kingdom
$263K +$261K +1,713 New
CPIA
145
Cornell Pochily Investment Advisors
New York
$253K -$6.86K -45 -3%
SF
146
Summit Financial
New Jersey
$253K +$34.3K +225 +16%
FAM
147
Family Asset Management
South Carolina
$250K
GWP
148
Gateway Wealth Partners
Wisconsin
$245K -$33.1K -217 -12%
SFP
149
Shepherd Financial Partners
Massachusetts
$241K
RWS
150
Resolute Wealth Strategies
Mississippi
$240K

FBT Hedge Fund Activity: Q1 2024 in Review

243 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2024, worth a combined $559M — down 25% from $746M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of FBT and 18 opened new positions — a net loss of 10 holders — while 97 trimmed existing stakes and 60 added.

The largest buyer was LPL Financial, adding an estimated $11.8M. The largest seller was Morgan Stanley, cutting an estimated $143M.

  • 243 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2024, down from 257 in Q4 2023.
  • Funds reported $559M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2024, down 25% quarter-over-quarter.
  • 18 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2024 and 28 closed out, a net change of -10 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2024 was LPL Financial, an estimated $11.8M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2024 was Morgan Stanley, an estimated $143M sold.

Based on aggregated 13F filings for Q1 2024.